It binds directly to IGF-1 receptors in muscle, bone, and adipose tissue, initiating anabolic cascades independent of upstream hormonal regulation
Diabetologia (2018) 61:28494
Obwohl wir uns stets bemhen sicherzustellen, dass die Informationen auf unserer Webseite aktuell sind, bitten wir darum, vor der Einnahme die Informationen auf dem Produktetikett und auf der Packung zu lesen
Gastrointestinal side effects were more common in the 7.2 mg group compared to the 2.4 mg group (70.8% vs 61.2%)
Research models show Tesamorelin may influence IGF-1 activity, enhance lipolytic gene expression, and support reductions in visceral adipose tissue (VAT)
Some patients ask about pairing it with GLP-1 options such as semaglutide, which works through a different mechanism aimed at overall weight